芒果视频下载

煙臺東(dong)誠(cheng)藥(yao)業(ye)集團股(gu)(gu)份有限公司（前身為煙臺東(dong)誠(cheng)生(sheng)化(hua)股(gu)(gu)份有限公司）成(cheng)立于1998年(nian)，2012年(nian)5月(yue)在深交所上市（股(gu)(gu)票(piao)代碼002675）。歷經20余年(nian)的發(fa)展，東(dong)誠(cheng)藥(yao)業(ye)現已成(cheng)為一(yi)家(jia)覆(fu)蓋(gai)生(sheng)化(hua)原料(liao)藥(yao)、化(hua)藥(yao)、中成(cheng)藥(yao)、核藥(yao)四大領(ling)域(yu)，融藥(yao)品研發(fa)、生(sheng)產、銷售于一(yi)體的大型制藥(yao)企業(ye)集團。

集(ji)團控股煙臺東誠(cheng)北(bei)方制藥有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、煙臺東誠(cheng)大洋制藥有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、臨沂東誠(cheng)東源生物(wu)工(gong)程有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、中(zhong)泰(tai)生物(wu)制品有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、東誠(cheng)國(guo)際(香港)有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、成(cheng)都云克藥業(ye)有(you)(you)(you)限(xian)(xian)(xian)責任公(gong)(gong)(gong)(gong)(gong)司(si)、上(shang)海(hai)(hai)欣科(ke)(ke)醫藥有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、上(shang)海(hai)(hai)益泰(tai)醫藥科(ke)(ke)技有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、南京(jing)江原安迪科(ke)(ke)正電子研(yan)究發展有(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)等40多家分子公(gong)(gong)(gong)(gong)(gong)司(si)，集(ji)團在北(bei)京(jing)、上(shang)海(hai)(hai)、南京(jing)設立研(yan)發分支機構和辦(ban)事處(chu)，擁有(you)(you)(you)員工(gong)近兩千人。

東(dong)誠(cheng)藥業(ye)作為國內前沿的生化(hua)原料(liao)藥生產(chan)(chan)企(qi)業(ye)，核心產(chan)(chan)品肝素鈉及硫(liu)酸軟骨(gu)素憑借優質質量(liang)，贏得(de)了眾(zhong)多(duo)的國際(ji)機(ji)構(gou)認證(zheng)，產(chan)(chan)品90%以上銷往(wang)歐洲(zhou)、美洲(zhou)、亞(ya)太等(deng)全球40多(duo)個國家和地(di)區(qu)，與(yu)眾(zhong)多(duo)國際(ji)知名藥企(qi)建立了穩定的合作關系。

東誠(cheng)藥業(ye)不斷(duan)強化制(zhi)劑業(ye)務，制(zhi)劑產品覆蓋心血管(guan)、抗腫(zhong)瘤(liu)、泌尿、骨科等(deng)治療(liao)領(ling)域。近年來，公(gong)司(si)高(gao)起點(dian)進(jin)入高(gao)技術壁壘和高(gao)成(cheng)長性的核醫(yi)藥行(xing)業(ye)，相繼并(bing)購國內多家核藥企業(ye)，完成(cheng)從(cong)診斷(duan)用核藥到治療(liao)用核藥的全產業(ye)鏈(lian)布(bu)局，奠定(ding)了公(gong)司(si)在中國核醫(yi)藥領(ling)域的前沿地位。

東誠藥業不斷加大科研投入，致(zhi)力自主(zhu)創新，引(yin)(yin)進泰山學者、973科學家等(deng)高素質人才。通(tong)過建立廣(guang)泛的(de)產學研合(he)作(zuo)網(wang)絡，實現新技術的(de)引(yin)(yin)進轉(zhuan)化，通(tong)過創新驅動(dong)帶領企(qi)業發展(zhan)。

在“立(li)足東方，誠(cheng)諾(nuo)健康”企(qi)業(ye)使命指(zhi)引下，東誠(cheng)藥(yao)業(ye)將深化資(zi)源整(zheng)合、優化產(chan)業(ye)結構、不(bu)斷(duan)提升企(qi)業(ye)創新能(neng)力(li)與核心競爭(zheng)力(li)，以“全球肝素(su)專家(jia)，中國核藥(yao)領(ling)軍企(qi)業(ye)”為(wei)(wei)目標，向著(zhu)成長為(wei)(wei)專業(ye)領(ling)域前沿(yan)的(de)、持續創造優異價值的(de)制藥(yao)企(qi)業(ye)不(bu)斷(duan)邁進。